Impact BioMedical Inc.
IBO
$0.55
-$0.03-5.64%
AMEX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 7.00K | 7.00K | 18.00K | 7.00K | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.00K | 7.00K | 18.00K | 7.00K | -- |
| Cost of Revenue | -- | 422.00K | 1.00K | 11.00K | -- |
| Gross Profit | 7.00K | -415.00K | 17.00K | -4.00K | -- |
| SG&A Expenses | 1.90M | 275.00K | 516.00K | 676.00K | 509.00K |
| Depreciation & Amortization | 285.00K | 286.00K | 288.00K | 288.00K | 283.00K |
| Other Operating Expenses | 67.00K | 72.00K | 109.00K | 110.00K | 115.00K |
| Total Operating Expenses | 2.30M | 1.17M | 966.00K | 1.16M | 1.01M |
| Operating Income | -2.29M | -1.16M | -948.00K | -1.15M | -1.01M |
| Income Before Tax | -2.28M | 2.66M | -1.48M | -14.35M | -1.28M |
| Income Tax Expenses | -- | -2.58M | -- | -- | -- |
| Earnings from Continuing Operations | -2.28M | 5.24M | -1.48M | -14.35M | -1.28M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -3.00K | 10.00K | 5.00K | 6.00K | 11.00K |
| Net Income | -2.29M | 5.25M | -1.47M | -14.35M | -1.27M |
| EBIT | -2.29M | -1.16M | -948.00K | -1.15M | -1.01M |
| EBITDA | -4.01M | -872.00K | -92.00K | -1.15M | -1.01M |
| EPS Basic | -0.02 | 0.06 | -0.12 | -1.18 | -0.11 |
| Normalized Basic EPS | -0.01 | 0.02 | -0.08 | -0.74 | -0.07 |
| EPS Diluted | -0.02 | 0.06 | -0.12 | -1.18 | -0.11 |
| Normalized Diluted EPS | -0.01 | 0.02 | -0.08 | -0.74 | -0.07 |
| Average Basic Shares Outstanding | 107.79M | 89.77M | 12.19M | 12.19M | 12.06M |
| Average Diluted Shares Outstanding | 107.79M | 89.77M | 12.19M | 12.19M | 12.06M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |